Drug recall · August 19, 2026
SEMAGLUTIDE 6.75mg recall
Why: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
SEMAGLUTIDE 6.75mg (4.5 mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202 NDC 71170-821-01
- Lots / codes
Lot: C-017115, Exp. 11/25/2026; AC-017163, Exp. 12/31/2026; AC-017169, AC-017170, AC-017171, Exp. 12/31/2026; AC-017230, AC-017231, Exp. 5/5/2027.
- Quantity
- 37,546 vials.
- Company
- Apollo Care, LLC, Columbia, MO
- Distribution
- Nationwide within the U.S
- Initiated
- July 29, 2026 · Voluntary: Firm initiated
- Classified
- August 7, 2026
- Reported
- August 19, 2026
- How notified
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.